Clinical Research Directory
Browse clinical research sites, groups, and studies.
Inositol in Letrozol Resistant PCOS Women
Sponsor: Kafrelsheikh University
Summary
Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.
Official title: Efficacy of Inositol in Managing Subfertility in Letrozole-resistant Polycystic Ovary Syndrome Women
Key Details
Gender
FEMALE
Age Range
18 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2025-05-10
Completion Date
2026-05-11
Last Updated
2026-06-17
Healthy Volunteers
No
Conditions
Interventions
Myoinositol
Combined myoinositol \& Dchiroinositol twice daily plus letrozole for 3 months
Metformin
Metformin 500mg twice daily plus letrozole for 3 months
Locations (1)
Kafrelshiekh university hospital
Cairo, Egypt